Literature DB >> 22870103

HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner.

Hideaki Mizutani1, Tetsuya Okano, Yuji Minegishi, Kuniko Matsuda, Junko Sudoh, Kazuhiro Kitamura, Rintaro Noro, Chie Soeno, Akinobu Yoshimura, Masahiro Seike, Akihiko Gemma.   

Abstract

Epithelial to mesenchymal transition (EMT) is induced by transforming growth factor-β1 (TGF-β1) and is a crucial event for cancer cells to acquire invasive and metastatic phenotypes. However, the signals that induce EMT in cancer cells have yet to be adequately defined. In this study, a proteomic investigation was performed to understand the signaling pathway of the EMT of lung cancer using two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry. The protein expression profiles of A549 were compared to those of A549 cells treated with TGF-β1. Of more than 2,000 protein spots shown by 2D-DIGE, 53 were found to be up- or down-regulated upon induction with TGF-β1. In the 53 protein spots, the protein level of heat shock protein (HSP) 27 was found to increase significantly. HSP27 protein was higher in two different lung cancer cell lines, demonstrating the EMT phenomenon with TGF-β1. Notably, the silencing of HSP27 enhanced spindle integration, resulting in an additive effect with TGF-β1-induced EMT. Furthermore, the TGF-β1-induced HSP27 increase was not affected by the suppression of Smad2 and Smad3 in A549 cells. These results suggest that HSP27 was involved in TGF-β1-induced EMT in a Smad-independent manner in lung cancer cells and may provide an effective clinical strategy in lung cancer patients whose tumors are dependent on TGF-β1-induced EMT.

Entities:  

Year:  2010        PMID: 22870103      PMCID: PMC3412513          DOI: 10.3892/ol.2010.190

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

Review 1.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

Authors:  Stefan Grünert; Martin Jechlinger; Hartmut Beug
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

2.  Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer.

Authors:  Helen K Berrieman; Lynn Cawkwell; Sara L O'Kane; Laura Smith; Michael J Lind
Journal:  Oncol Rep       Date:  2006-01       Impact factor: 3.906

3.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Authors:  Anurag Singh; Patricia Greninger; Daniel Rhodes; Louise Koopman; Sheila Violette; Nabeel Bardeesy; Jeff Settleman
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Identification and characterization of hic-5/ARA55 as an hsp27 binding protein.

Authors:  Y Jia; R F Ransom; M Shibanuma; C Liu; M J Welsh; W E Smoyer
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

6.  High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

Authors:  R M Bremnes; R Veve; E Gabrielson; F R Hirsch; A Baron; L Bemis; R M Gemmill; H A Drabkin; W A Franklin
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

7.  Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry.

Authors:  George Deeb; Jianmin Wang; Nithya Ramnath; Harry K Slocum; Sam Wiseman; Amy Beck; Dongfeng Tan
Journal:  Mod Pathol       Date:  2004-04       Impact factor: 7.842

8.  Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.

Authors:  Jin Kyung Rho; Yun Jung Choi; Jin Kyung Lee; Baek-Yeol Ryoo; Im Il Na; Sung Hyun Yang; Cheol Hyeon Kim; Jae Cheol Lee
Journal:  Lung Cancer       Date:  2008-07-02       Impact factor: 5.705

9.  Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis.

Authors:  Hongqin Zhuang; Weiwei Jiang; Wei Cheng; Kui Qian; Wei Dong; Lin Cao; Qilai Huang; Shufeng Li; Fei Dou; Jen-Fu Chiu; Xue-Xun Fang; Min Lu; Zi-Chun Hua
Journal:  Lung Cancer       Date:  2009-06-21       Impact factor: 5.705

10.  Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

Authors:  Akihiko Gemma; Cai Li; Yuka Sugiyama; Kuniko Matsuda; Yoko Seike; Seiji Kosaihira; Yuji Minegishi; Rintaro Noro; Michiya Nara; Masahiro Seike; Akinobu Yoshimura; Aki Shionoya; Akiko Kawakami; Naoki Ogawa; Haruka Uesaka; Shoji Kudoh
Journal:  BMC Cancer       Date:  2006-06-30       Impact factor: 4.430

View more
  14 in total

Review 1.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

2.  Hsp27 regulates epithelial mesenchymal transition, metastasis and proliferation in colorectal carcinoma.

Authors:  Lu Han; Yong Jiang; Dongxing Han; Weilin Tan
Journal:  Oncol Lett       Date:  2018-08-09       Impact factor: 2.967

3.  MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells.

Authors:  Mengru Cao; Masahiro Seike; Chie Soeno; Hideaki Mizutani; Kazuhiro Kitamura; Yuji Minegishi; Rintaro Noro; Akinobu Yoshimura; Li Cai; Akihiko Gemma
Journal:  Int J Oncol       Date:  2012-06-28       Impact factor: 5.650

Review 4.  Heat shock proteins in multiple myeloma.

Authors:  Lei Zhang; Jacqueline H L Fok; Faith E Davies
Journal:  Oncotarget       Date:  2014-03-15

5.  Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma.

Authors:  Yaodong Zhu; Yanqing Liu; Yayun Qian; Xiaojun Dai; Ling Yang; Jue Chen; Shiyu Guo; Tadashi Hisamitsu
Journal:  BMC Complement Altern Med       Date:  2014-11-05       Impact factor: 3.659

6.  Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer.

Authors:  Yan Fang; Juan Wang; Guanwen Wang; Chen Zhou; Peng Wang; Shuangtao Zhao; Shaorong Zhao; Shan Huang; Weijun Su; Pengling Jiang; Antao Chang; Rong Xiang; Peiqing Sun
Journal:  Oncotarget       Date:  2017-04-18

7.  Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.

Authors:  Yiyang Liu; Jian Qian; Xiao Li; Wei Chen; Aiming Xu; Kai Zhao; Yibo Hua; Zhengkai Huang; Jianzhong Zhang; Chao Liang; Shifeng Su; Pu Li; Pengfei Shao; Jie Li; Chao Qin; Zengjun Wang
Journal:  Oncotarget       Date:  2016-12-06

8.  HSP27 associates with epithelial-mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma.

Authors:  Wei Chen; Xiaohua Ren; Jiashun Wu; Xiaolei Gao; Xiao Cen; Shasha Wang; Surui Sheng; Qianming Chen; Ya-Jie Tang; Xin-Hua Liang; Ya-Ling Tang
Journal:  J Cell Mol Med       Date:  2018-02-09       Impact factor: 5.310

9.  Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.

Authors:  Yeo-Jin Choi; Ga-Young Baek; Hae-Ran Park; Sung-Kee Jo; Uhee Jung
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.

Authors:  Myung-Shin Lee; Jisu Lee; Suhyuk Lee; Seung-Min Yoo; Joo Heon Kim; Won Tae Kim; Wun-Jae Kim; Jinsung Park
Journal:  Oncotarget       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.